QuidelOrtho Corporation, a leading player in the diagnostics industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1979, the company has achieved significant milestones, including the merger of Quidel Corporation and Ortho Clinical Diagnostics, which enhanced its market position and product offerings. QuidelOrtho specialises in innovative diagnostic solutions, focusing on areas such as infectious disease testing, women's health, and blood typing. Their core products, including rapid diagnostic tests and laboratory instruments, are distinguished by their accuracy and speed, catering to the evolving needs of healthcare providers. With a strong commitment to quality and innovation, QuidelOrtho has established itself as a trusted name in the diagnostics sector, recognised for its contributions to improving patient outcomes globally.
How does QuidelOrtho's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
QuidelOrtho's score of 30 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, QuidelOrtho reported total carbon emissions of approximately 22,544,000 kg CO2e for Scope 1 and about 29,690,000 kg CO2e for Scope 2 (market-based). This represents a decrease from 2022, where emissions were approximately 26,212,000 kg CO2e for Scope 1 and about 28,369,000 kg CO2e for Scope 2 (market-based). QuidelOrtho's emissions data is not cascaded from any parent organisation, indicating that these figures are solely from their operations. The company has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or initiatives as part of their climate commitments. Overall, QuidelOrtho's emissions reflect their ongoing efforts to monitor and manage their carbon footprint, although further commitments and reduction strategies would enhance their sustainability profile.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 26,212,000 | 00,000,000 |
| Scope 2 | 28,369,000 | 00,000,000 |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
QuidelOrtho has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

